| イタリア | トルコ | オーストリア | |
| 陽子線治療 | から $70,000 | から $70,000 | から $80,000 |
| 開頭術 | から $25,000 | から $5,650 | から $20,000 |
| 脳腫瘍摘出術 | から $40,000 | から $19,710 | から $60,000 |
| 脳腫瘍摘出術 | から $45,000 | から $7,030 | から $60,000 |
| 脳腫瘍に対する放射線療法 | から $12,000 | から $2,000 | から $15,000 |
Bookimedは脳腫瘍治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。脳腫瘍治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。脳腫瘍治療の旅路でお一人になることはありません。
Dr. Ignazio Borghesi heads the Neurosurgery Unit at Maria Cecilia Hospital. He has performed over 4,500 complex cranial and spinal procedures. His team completes approximately 1,000 surgeries every year. Dr. Borghesi uses 4K 3D digital imaging for enhanced surgical precision. He focuses on minimally invasive techniques for brain and spinal conditions.
Dr. Enrico Motti performs over 500 Gamma Knife procedures per year at Maria Cecilia Hospital. He specializes in treating inoperable intracranial tumors, vascular lesions, and trigeminal neuralgia. Dr. Motti holds a patent for interfacing stereotaxic equipment with CT scanning methods. He coordinates the Gamma Knife unit at a JCI-accredited facility in Italy.
医師はMater Olbia病院の神経外科ユニットのディレクターを務め、ローマのUniversità Cattolica del Sacro Cuoreの助教授でもあります。ChietiのUniversità G. D’Annunzioで医学と外科の学位を取得し、Università Cattolica del Sacro Cuoreで神経外科の専門を修了した医師は、神経腫瘍学、血管、脊椎の病理に焦点を当てています。最小侵襲技術を強調し、術中CTスキャン、超音波、ニューロナビゲーションなどの最先端技術を活用しています。医師は4000以上の外科手術を行い、そのうち2000以上は主任外科医として行いました。<\/p>
Italy features globally recognized neurosurgical centers like Istituto Neurologico Carlo Besta and Ospedale San Raffaele in Milan. These IRCCS-accredited facilities lead in complex brain tumor removals. They provide advanced technologies like Gamma Knife radiosurgery and 4K 3D micro-surgical imaging for precise tumor targeting.
Bookimed Expert Insight: Milan serves as Italy’s primary neurosurgical hub due to the density of IRCCS-accredited research hospitals. Facilities like San Raffaele and Galeazzi Sant-Ambrogio maintain high ratings of 4.6 to 4.9. This high volume directly correlates with specialized expertise. For example, some surgeons in these networks perform over 1,000 annual procedures. Patients should prioritize clinics with these dual research-clinical designations for the most current treatment protocols.
Patient Consensus: Patients note that Milan and Rome are the primary destinations for specialized tumor care. They emphasize checking a surgeon's specific volume in tumor types like gliomas or meningiomas rather than general credentials.
Italy features globally recognized neurosurgeons specializing in brain tumor treatment at JCI-accredited and IRCCS research hospitals. Specialists like Dr. Ignazio Borghesi and Dr. Giovanni Sabatino utilize 4K 3D imaging and intraoperative CT scans. These experts perform thousands of complex microsurgeries with high success rates.
Bookimed Expert Insight: Data shows a high concentration of neurosurgical expertise in Milan and Ravenna. Maria Cecilia Hospital stands out for specialized volume. Their team performs around 1,000 advanced neurosurgical procedures annually. This high frequency often correlates with better patient outcomes in complex cranial cases. Patients should look for surgeons like Dr. Borghesi who use 4K 3D digital microscopy for enhanced precision.
Patient Consensus: Patients emphasize prioritizing surgeons with specific experience in awake surgery or 5-ALA fluorescence. They note that while public care is excellent, going private in Milan or Rome significantly speeds up the treatment timeline.
Italy offers high-precision non-surgical brain tumor treatments including Gamma Knife, CyberKnife, and proton therapy. These technologies target tumors with sub-millimeter accuracy while sparing healthy tissue. Italian centers like Maria Cecilia Hospital and San Raffaele specialize in these advanced radiosurgery and particle therapy protocols.
Bookimed Expert Insight: Data shows Italy is a hub for high-volume radiosurgery. Dr. Enrico Motti at Maria Cecilia Hospital performs over 500 Gamma Knife procedures annually. This level of specialization is rare. While many patients focus on the technology, our data indicates that choosing a center with a dedicated Gamma Knife Society member ensures higher treatment precision and better long-term monitoring.
Patient Consensus: Patients report that treatments like proton therapy can lead to significant tumor shrinkage without the scalp burns associated with older radiation methods. Many note that returning to work is possible within weeks after Gamma Knife sessions.
Clinical trials for high-grade and recurrent brain tumors are active in Italy. Major neurological centers in Milan, Bologna, and Rome lead research into glioblastoma and IDH-mutant gliomas. Patients can access targeted therapies like niraparib or innovative methods like blood-brain barrier opening using focused ultrasound.
Bookimed Expert Insight: IRCCS accreditation is a powerful quality signal in Italy. Only a limited number of institutions receive this status from the Ministry of Health. Centers like San Raffaele or San Donato maintain these high standards. Our data shows these facilities often handle the most complex neuro-oncological cases across Europe. For patients seeking trials, focusing on IRCCS-certified hospitals in Milan or Bologna ensures you are at a facility specifically funded for clinical research.
Patient Consensus: Patients emphasize getting genetic profiling for MGMT and IDH markers early to match trial eligibility. Many note that bureaucracy can be a barrier, so starting the application process months before a potential recurrence is vital.
Advanced diagnostic staging in Italy utilizes high-resolution neuroimaging and molecular profiling to map tumor margins. Italian centers employ multiparametric MRI and hybrid PET/MRI with 18F-FET tracers to delineate infiltration. Genetic biomarkers like MGMT and IDH status integrate with AI-driven radiomics to customize treatment plans.
Bookimed Expert Insight: Italian neurosurgery units like Maria Cecilia Hospital often combine diagnostic depth with high surgical volume. Dr. Ignazio Borghesi performs around 1,000 procedures annually. This volume is critical because high-capacity centers typically offer specialized diagnostic tools like 4K 3D digital microscopy. These technologies are often reserved for facilities handling the highest complex case counts.
Patient Consensus: Patients note that combining PET-MRI with 18F-FET tracers provides a much clearer picture of tumor spread than standard scans. Many emphasize requesting a multidisciplinary tumor board review at major centers to ensure all diagnostic data is considered together.
Italian hospitals accommodate international brain tumor patients through dedicated offices managing medical visas, multi-lingual coordination, and advanced neurosurgical care. Facilities like San Raffaele and Maria Cecilia Hospital integrate high-tech diagnostics with logistical support. Precise planning ensures seamless access to specialized treatments within JCI-accredited environments.
Bookimed Expert Insight: Italy presents a unique high-volume advantage for complex neurosurgery often overlooked by international patients. Maria Cecilia Hospital alone handles 15% of the country’s cardiac surgeries and holds JCI accreditation. Dr. Enrico Motti, with over 40 years of experience, pioneered Gamma Knife protocols in the region. This concentration of veteran expertise in private networks typically offers faster surgical scheduling than general public systems.
Patient Consensus: Patients highlight that while medical care is excellent, administrative paperwork is challenging without professional help. They recommend contacting international desks 2–3 months early to coordinate visas and suggest using translation apps to bridge daily language gaps.
Patients should ask Italian neuro-oncologists about specific tumor mutations like MGMT methylation and IDH status. Inquire about the centers IRCCS accreditation and multidisciplinary team structure. Confirm the surgeons annual volume for your specific tumor type. Italy offers advanced techniques like 3D orbital camera technology and Gamma Knife.
Bookimed Expert Insight: While many seek care in Rome, Milan is the primary hub for high-volume neuro-oncology. Clinics like San Raffaele and Galeazzi-Sant Ambrogio serve over 300,000 patients yearly. This massive volume often grants patients faster access to multidisciplinary boards. Coordination between neurosurgeons and radiotherapy specialists is more streamlined in these large IRCCS-accredited research hospitals.
Patient Consensus: Patients emphasize getting molecular profiling done immediately to avoid treatment delays. Many recommend bringing typed questions in both Italian and English to ensure every detail is covered.
Italian neurosurgery centres offer brain tumour technologies including Gamma Knife radiosurgery, CyberKnife, and proton therapy. Specialists use intraoperative MRI and neuronavigation to improve tumour resection accuracy. Leading facilities like San Raffaele and Maria Cecilia Hospital integrate these tools into neuro-oncology care.
Bookimed Expert Insight: Italian neurosurgery is defined by the IRCCS designation. This accreditation from the Ministry of Health marks clinics that must integrate research with clinical care. For patients, this means faster access to newer techniques like sonodynamic therapy.
Australian patients should check an Italian specialist's case volume and sub-specialisation in specific tumour types. Priority centres hold IRCCS accreditation from the Italian Ministry of Health. Specialists should offer technologies like Gamma Knife, neuronavigation, and intraoperative fluorescence for precision.
Bookimed Expert Insight: Italian neurosurgery excels in high-density technology hubs. Many clinics offer standard surgery. However, Maria Cecilia Hospital stands out for combining JCI accreditation with specific Gamma Knife and stereotaxic units. Specialists there, such as Dr Enrico Motti, often hold international patents for neurosurgical equipment. This reflects a deeper level of technical innovation than general oncology centres.
Patient Consensus: Patients note it is essential to request a second review of Australian imaging before travel. They emphasise finding a specialist who coordinates the full pathway. This should include everything from biopsy through to rehabilitation and English documentation.
Italy offers brain tumour treatments including microsurgery, Gamma Knife radiosurgery, and particle therapies like proton and carbon ion therapy. Specialist JCI-accredited centres such as Maria Cecilia Hospital and San Raffaele use neuronavigation and intraoperative imaging. These tools allow high precision during complex tumour removals.
Bookimed Expert Insight: Italian neurosurgery units operate with high patient volumes and specialised leadership. Dr Ignazio Borghesi at Maria Cecilia Hospital leads a team performing 1,000 procedures annually. Dr Enrico Motti manages over 500 Gamma Knife sessions yearly. This high-frequency expertise often leads to better preservation of motor and cognitive skills.
Patient Consensus: Patients value the multidisciplinary approach in Italy where surgery, radiation, and oncology are coordinated. Integrated pathways that include on-site pathology and follow-up imaging are highly praised for efficiency.
Italian neurosurgeons and oncologists at leading research centres generally possess high English proficiency. Specialists often complete international fellowships or lead global research. For example, Dr Ignazio Borghesi at Maria Cecilia Hospital trained in Zurich and Florida. However, English levels among nursing and administrative staff vary significantly across different institutions.
Bookimed Expert Insight: Italian neurosurgery is highly concentrated. Maria Cecilia Hospital is specifically ranked best for neurosurgery by international patients. This hospital is also JCI-accredited. Choosing JCI-certified centres typically results in more consistent English-speaking support. This is because these clinics must meet strict international communication standards for patient safety.
Patient Consensus: Patients recommend requesting written confirmation that an interpreter will attend scans and discharge meetings. They also suggest asking for medical reports and pathology results in English before leaving Italy.
Australian patients should ask about cognitive effects and neurosurgical risks like fluid leaks. They should also enquire about seizure management. Ask how radiation or chemotherapy side effects are monitored. Confirm protocols for reporting concerns once home. Check how Italian specialists manage medications compared to Australian GPs.
Bookimed Expert Insight: Italian neurosurgery units like Maria Cecilia Hospital often use 4K 3D digital imaging. This technology helps surgeons see tumours clearly. This can reduce the risk of damaging healthy brain tissue. Patients should ask if the surgeon uses intraoperative CT to verify removal. This may lower the chance of needing a second surgery.
Patient Consensus: Patients value how Italian clinics like San Raffaele handle complex research-based cases. Many note that clear plans for emotional support help with the transition back home. Follow-up care plans also help ease the return to Australia.
Italy hosts several internationally recognised hospitals for brain tumour treatment. These centres specialise in complex neurosurgical oncology and radiosurgery. Milan serves as a primary hub. Facilities like San Raffaele and Maria Cecilia Hospital maintain JCI and IRCCS accreditations for research and surgery.
Bookimed Expert Insight: While Milan is the traditional medical hub, Maria Cecilia Hospital in Bologna is a standout choice. It holds JCI accreditation and was ranked top for neurosurgery by international patients in 2019. Dr Enrico Motti there performs over 500 Gamma Knife procedures annually. This volume is significant for patients seeking non-invasive options for intracranial lesions.
Patient Consensus: Patients note that choosing a specialist surgeon matters more than the hospital brand alone. Many recommend seeking a multidisciplinary tumour board review in Milan or Bologna to confirm the best approach.